Archive for FDA

Abortion Weaponization Playbook: strategy to enshrine and expand abortion in America

Posted in Abortion Pill Connections, ANSIRH, expand abortion, Guttmacher, Gynuity, Hollywood, Hyde Amendment, Pro-choice Strategy, RHA, Self Managed Abortion, self-managed abortion, Tax Payer Funding of Abortion, Teen Abortion, Teen Pregnancy with tags , , , , , , , , , , , , , , , , , , , , , , , on June 8, 2019 by saynsumthn
When Planned Parenthood and the media claim “abortion laws” are part of a long held strategy to dismantle Roe and ban abortion- as demonstrated in these Tweets….remind them that it is the abortion lobby that has had a long held strategy to weaponize abortion, as I will demonstrate below.

REMIND them that the abortion lobby and Planned Parenthood want to WEAPONIZE abortion and there has been a strategy to expand abortion: 

#1) Click to READ: EXPOSED: Abortion groups’ plan to ‘increase supply and demand’ for abortion   

A 92-page report on the Tara Health Foundation website should be reviewed by pro-life advocates across the nation, as it details upcoming strategy from abortion supporters, which includes the push for “home use” abortions. The document, as detailed at Live Action News reveals pro-abortion legislative and litigation strategies suggested in the report include:

  • REMS removal strategy (This is the risk management system that governs the abortion pill RU486)
  • TRAP laws removal advocacy
  • Gestational bans removal advocacy
  • Criminality of self-induced abortion removal advocacy
  • Organizing led by women of color (WOC)
  • Reproductive health or democracy reform PAC donations
  • Reproductive justice PAC donations
  • The plan committed to “increasing access for people with low incomes” even “where abortion… becomes inaccessible or is banned completely.”

TARA Health Foundation Abortion strategy

 

#2). Click to Read: Planned Parenthood’s 3-part plan for 2019: Abortion, Abortion, Abortion 

This Live Action News piece, documents that earlier this year, Planned Parenthood released its plan for 2019, and despite  declining clients and health services, the plan reveals the organization’s continued obsession with abortion. The “multi-million dollar” plan was announced by the group’s political advocacy arm, Live Action News reports.
According to PP’s document and the Live Action News article, the largest provider of abortion planned to do the following:

Expand abortion using a Regional Access Network the abortion chain’s plans include:

  • A Regional Access Network anywhere abortion either becomes inaccessible or is banned completely
  • Facilitate telehealth care and transportation for patients facing obstacles to abortion
  • Opening new abortion facilities
  • Expanding medication abortion services
  • Expanding telemedicine services to increase abortion access for clients in remote communities

Legislative efforts to expand tax funded abortion, the plan will target 10 states, including:

  • Illinois, where Planned Parenthood is pushing public funding of abortion and ways the state can “codify the right to abortion in state law”
  • Maine, where Planned Parenthood is “moving to ensure women insured through public programs can have… abortion”
  • Rhode Island. where Planned Parenthood “will work in the 2019 legislative session to codify the right to…abortion in state law”
  • Oregon, where Planned Parenthood “is implementing the Reproductive Health Equity Act to guarantees no-cost coverage for… abortion”
  • Hawaii, where Planned Parenthood “is working to expand access to…abortion by advancing comprehensive coverage of… abortion”
  • Washington, where Planned Parenthood “is focusing on passing the Reproductive Health Equity Access bill” to remove barriers to abortion

Use Hollywood and media to “destigmatize abortion” the plan vows to:

  • Work with “content creators” on portraying abortion positively in film and television
  • Create resources to encourage, “accurate, non-judgmental conversations about abortion…”
  • Use technology to “help people understand the reality of safe, legal abortion and what patients experience when having an abortion”

#3) Click to Read Guttmacher Institute releases plan to expand abortion in 7 ways 

Live Action News documents how, the Guttmacher Institute, Planned Parenthood’s former “special affiliate,” has published a new “policy review,” titled, “Ensuring Access to Abortion at the State Level.
The document is broken down by several strategy subjects:
  • Affirming and Protecting the Right to Abortion
  • Providing Abortion Coverage
  • Ensuring Access to Information
  • Supporting Adolescents’ Access
  • Preventing Clinic Violence
  • Expanding the Pool of Abortion Providers
  • Creating a Safe Policy Environment for Self-Managed Care
  • Expanding Online and Telehealth Access

Paraphrased by Live Action News as follows:

  • 1) Push statutory and constitutional measures to codify abortion
  • 2) Increase taxpayer-funded abortion
  • 3) Force insurance companies to cover abortion
  • 4) Eliminate informed consent 
  • 5) Increase abortion customers
  • 6) Allow non-physicians to commit abortions
  • 7) Push “self-managed abortions”

#4) Advancing New Standards in Reproductive Health (ANSIRH), Gynuity Health Projects, and Ibis Reproductive Health  

According to another Live Action News report, “A consortium of abortion organizations — Advancing New Standards in Reproductive Health (ANSIRH), Gynuity Health Projects, and Ibis Reproductive Health — published a report entitled, “A roadmap for research on self-managed abortion in the United States.” The report suggested, [M]edication abortion could be even further demedicalized through pharmacy dispensing and expansion of telemedicine models—or even making it available over the counter (OTC)—which have the potential to expand access greatly.”

And…what do you know? Abortion organizations are pushing to expand abortion like never before, by attempting to influence the FDA to remove important safety regulations, called REMS which will enable them to sell the dangerous abortion pills online.

The Document claims these groups are planning to: 

  • Expand direct-to-patient telemedicine with various options, such as:
  • Use of phone rather than videoconferencing. 
  • Web-based interface for patient interactions and for recording clinical and research data.
  • Provision of medication abortion pills from a central pharmacy rather than from each clinician’s office.
  • Elimination of the requirement for screening ultrasound and lab tests (i.e., implement screening based entirely on history).
  • Home-based follow-up methods using urine pregnancy testing.
  • Study the uptake, safety, and effectiveness of advance provision of medication abortion pills.
  • Undertake an OTC label comprehension study and develop and implement an actual use study in a simulated OTC environment.
  • Identify ways to improve access in legally restricted settings using data from research with online providers and smartphone apps.

All pro-life groups need to read the abortion weaponization playbooks outlines above.

SHARE THIS Article!

 

Abortion groups tell women to lie about abortion pill, claim miscarriage

Posted in Abortion pill, Abortion Pills Illegal, DANCO, Packard Foundation, Self Managed Abortion, self-managed abortion with tags , , , , , , , , , , , , , , , , , , , on June 2, 2019 by saynsumthn

abortion pill

Just as abortion supporters rage over new pro-life laws in Georgia and Alabama, claiming that women could be investigated for miscarriages, comes proof that abortion supporters are actually advising women who experience complications from illegal use of the abortion pill to lie to health care providers and say they had miscarriages.

Currently, abortion insiders, many with ties to abortion pill manufacturer Danco, are pushing for expansion of the abortion pill, despite thousands of adverse effects and two dozen deaths. The abortion pill regimen consists of two drugs: Mifepristone  (or Mifeprex) and Misoprostol. The FDA has warned women against purchasing these dangerous pills online.

Dr. Daniel Grossman, a professor of obstetrics and gynecology at the University of California, San Francisco, who also teaches abortion allegedly told a reporter at The Atlantic that if women using these [self-managed abortion] regimens experience heavy bleeding or some other complication, they are generally advised to go to a hospital and say they had a miscarriage.

Grossman is behind clinical trials to expand the abortion pill for pharmacy dispension and is calling to remove important safety requirements put in place by the FDA, called REMS. This comes as no surprise, as one of the major original investors of abortion pill manufacturer Danco — The Packard Foundation — has funded other Grossman-authored studies. In other words, those behind the studies attempting to do away with FDA safety requirements for the abortion pill stand to gain a significant amount of money if those requirements are removed.

Image: Packard Foundation invested in abortion pill manufacturer DANCO (Image: David and Lucile Packard Foundation )

Packard Foundation invested in abortion pill manufacturer DANCO (Image: David and Lucile Packard Foundation )


If you think you might have a complication you should go to a doctor immediately. If you live in a place where abortion is a crime and you don’t have a doctor you trust, you can still access medical care. You do not have to tell the medical staff that you tried to induce an abortion; you can tell them that you had a spontaneous miscarriage. Doctors have the obligation to help in all cases and know how to handle a miscarriage.
The international abortion organization, Women on Web, advises women on its website to present to the ER and claim they are having a miscarriage if they experience complications from the abortion pill in a country where taking the drug is illegal:

The symptoms of a miscarriage and an abortion with pills are exactly the same and the doctor will not be able to see or test for any evidence of an abortion, as long as the pills have completely dissolved. 

Women on Web advises women lie about illegal abortion pill emergencies say miscarriage (accessed 5/14/2019)

According to a report from The Atlantic, Women on Web’s founder, Rebecca Gomperts, launched the site Aid Access to sell the abortion pill online, against FDA requirements. The FDA recently issued Aid Access a warning letter to cease its illegal activity. Last week, over 100 lawmakers sent a letter to the FDA, asking it to continue to monitor and crack down on dangerous websites like Aid Access.

But that has not stopped other proponents of self-managed abortion, who seem set on placing women in harm’s way. The website Plan C, founded in 2015 by Francine Coeytaux and Elisa Wells, tells women, “Those who choose to self-manage their abortion have no obligation to report that they have used misoprostol and there is no way it can be detected in the body, even if a blood test is taken. Scientists have found that there is no noticeable difference between a naturally occurring miscarriage and the bleeding that happens after taking misoprostol.”

Plan C Website FAQ where get

Then, if something goes wrong (and it most likely will), the Plan C website, which is under the fiscal sponsorship of the National Women’s Health Network, advises women to present to the emergency room or other health care offices and simply claim they are experiencing a miscarriage.

PlanC website tells women aborting to present with Miscarriage, accessed 5/14/2019

Live Action News previously reported how abortion organization, Reproaction, purchased over $4,000 in ads to promote a push for self-managed abortion — something unapproved by the FDA. Reproaction also advises women to seek care by lying about their abortions.

A webinar published in 2018 states in part that women “need information to reduce the risk of arrest… what the signs of a complication are and most importantly what to say if one needs to go to the doctor…. [T]he symptoms of an abortion with pills and miscarriage are exactly the same and the treatment for any kind of complication is exactly the same…. It’s important for people to understand there’s no test for these pills in blood or urine so if they present with a miscarriage they can get the healthcare that they need….”

tweet from “Helen Bolton” — whose profile implies that he or she is with organized abortion groups “ and ” — reiterates the deception being proposed: “Misoprostol is basically OTC in a lot of the world and is regularly used to self-manage abortions in places where it’s illegal. Even with complications, the patient looks like they had a miscarriage, so people can go to a hospital (provided miscarriages aren’t investigated).”

Abortion supporter advises women lie about illegal abortion pill emergencies say miscarriage (Image: Twitter)

Others have made similar suggestions.

Abortion supporter advises women lie about illegal abortion pill emergencies say miscarriage (Image: Twitter)

FDA warns women: “Do Not Buy Mifeprex Over the Internet.

FDA warns consumers to not buy abortion pills over the internet

The FDA adds, “You should not buy Mifeprex over the Internet because you will bypass important safeguards designed to protect your health (and the health of others). Mifeprex has special safety restrictions on how it is distributed to the public. Also, drugs purchased from foreign Internet sources are not the FDA-approved versions of the drugs, and they are not subject to FDA-regulated manufacturing controls or FDA inspection of manufacturing facilities.”

According to the FDA’s adverse effects reports through 2018, there have been reports of 24 deaths associated with Mifeprex since the product was approved in September 2000, as well as 4,200 reported adverse effects, including hospitalization and other serious complications.

  • This article is reprinted with permission. The original appeared here at Live Action News.

Group vows to defy FDA, continues dispensing abortion pills illegally

Posted in Abortion pill, Abortion Pill Connections, Abortion Pill Horrors, Abortion Pills Illegal, DANCO, FDA, Illegal abortion, Population Control with tags , , , , , , , , on June 1, 2019 by saynsumthn

abortion pill

Just days after 100 lawmakers sent a letter to the Food and Drug Administration (FDA) — which oversees drug safety — requesting that the FDA monitor abortion group Aid Access for illegally dispensing abortion pills, Aid Access announced its intent to defy the FDA’s warnings to “immediately cease” dispension of the drugs.

Aid Access founder Rebecca Gomperts published her response on Aid Access’s website as well as on Women on Waves, another organization Gomperts founded in 1999. Gomperts claims, “Last year, I prescribed 2,581 medical abortions out of 11,108 women who consulted me.”

Gomperts states in part:

On March 8, 2019, I received a letter from the FDA ordering my new (since 2018) organization, Aid Access, to stop providing telemedical abortion services to women who cannot otherwise access safe abortions because of costs, domestic violence, distance, or other reasons, and who do not have access to other doctors willing or able to prescribe misoprostol and mifepristone.

This letter was applauded by Republican members of Congress, of whom 92 percent are male.

But I will not be deterred. When U.S. women seeking to terminate their pregnancies prior to 9 weeks consult me, I will not turn them away. I will continue to protect the human and constitutional right of my patients to access safe abortion services.

Notably, the Congressional letter was signed by a number of women in Congress, including Reps. Martha Roby, Carol D. Miller, Virginia Foxx, Liz Cheney, Ann Wagner, Jenniffer González Colón, Debbie Lesko, and several medical doctors who also serve in the House of Representatives, among many others.

Rebecca Gomperts founder of Aid Access defiant to offer illegal abortion pills online

In a statement to Live Action News, the FDA wrote:

As noted in the FDA warning letter to AidAccess issued on March 8, 2019, failure to correct the violations of the law may result in FDA regulatory action, including seizure or injunction, without further notice. We cannot comment on a potential future action at this time, but we remain very concerned about the sale of unapproved mifepristone for medical termination of early pregnancy on the Internet, because this bypasses important safeguards designed to protect women’s health. Unapproved drugs purchased from foreign internet sources are not the FDA-approved versions of the drugs, and therefore, they are not subject to FDA-regulated manufacturing controls or FDA inspection of manufacturing facilities. Drugs that have circumvented regulatory safeguards may be contaminated, counterfeit, contain varying amounts of active ingredients, or contain different ingredients altogether.

The statement went on to say that “The FDA’s regulation and oversight of the drug approval process and drug distribution helps to protect patients by applying rigorous scientific and safety standards, requiring labeling review for accuracy and completeness, and working to ensure that counterfeit and unsafe medicines do not enter the U.S. drug supply. When these requirements are not met, FDA can step in to help protect consumers.” The FDA reiterated that it has warned AidAccess.org and Rablon that they are in violation of the Federal Food, Drug, and Cosmetic Act for causing the introduction of unapproved new drugs into U.S. commerce.

Drugs are tightly regulated by the FDA for a reason, and under current requirements, the abortion pill — also known as Mifeprex or Mifepristone — is only permitted to be dispensed in hospitals or clinics by medical personal who are approved prescribers of the pill. FDA placed Mifeprex under a tighter regulatory system known by the acronym REMS (Risk Evaluation and Mitigation Strategy), “a safety strategy to manage a known or potential serious risk associated with a medicine and to enable patients to have continued access to such medicines by managing their safe use.”

Under the Mifepristone REMS Program, the FDA states, “Mifeprex and the approved generic version of Mifeprex” may:

  • [O]nly be supplied directly to healthcare providers who are certified to prescribe the drug product and who meet certain qualifications.
  • [T]he products are only available to be dispensed in certain healthcare settings, specifically, clinics, medical offices and hospitals, by or under the supervision of a certified prescriber.
  • They are not available in retail pharmacies and are not legally available over the Internet.

The FDA has warned women against purchasing these dangerous pills online: “Do Not Buy Mifeprex Over the Internet.

FDA warns consumers to not buy abortion pills over the internet

The FDA adds, “You should not buy Mifeprex over the Internet because you will bypass important safeguards designed to protect your health (and the health of others). Mifeprex has special safety restrictions on how it is distributed to the public. Also, drugs purchased from foreign Internet sources are not the FDA-approved versions of the drugs, and they are not subject to FDA-regulated manufacturing controls or FDA inspection of manufacturing facilities.”

READ: AWFUL: Abortion groups tell women to lie about abortion pill, claim miscarriage

Weeks ago, the FDA updated its adverse events report through 2018, documenting “24 deaths of women associated with Mifeprex since the product was approved in September 2000….” The FDA also noted at least 4,200 additional adverse effects. Under 2016 changes, the drug’s manufacturer, Dancono longer has to report non-fatal adverse effects, so we can only imagine what the number really is.

Abortion Pill Deaths December 2018

Dec 2018 abortion pill deaths FDA

Live Action News previously documented a larger push by pro-abortion organizations to lift the FDA’s REMS requirements, to expand abortion pill dispension to mail order and online sales, via self-managed abortions. And we also documented the secretive history of Danco’s investors, which include organizations such as the Packard Foundation and other abortion philanthropists, who appear to stand to gain financially from a broad abortion pill expansion. The original drug, Mifeprex, was approved in 2000 after being brought to the U.S. by the eugenics-founded Population Council.

The defiance by Aid Access comes on the heels of multiple pro-life bills being passed in several states. Pro-abortion organizations, who used to claim that self-abortions injure and even kill women, now appear willing to place them in harm’s way. In addition, when these same women experience serious complications from these dangerous pills, they are instructed to present to the ER and lie, claiming they had a miscarriage. Ironically, while the abortion lobby shows support to Aid Access, they simultaneously want to discredit the science behind abortion pill reversal.

Editor’s Note 5/17/19: This article was edited to include a statement from the FDA.

  • This article is reprinted with permission. The original appeared here at Live Action News.

FDA: 24 women die from abortion pill, thousands of serious complications

Posted in AAPLOG, Abortion death, Abortion pill, Abortion Pill Connections, Abortion Pill Horrors, DANCO, Daniel Grossman, Generic Abortion Pill, Inc., Packard Foundation with tags , , , , , , , , , , , , , , , , , , , , , , , , on April 23, 2019 by saynsumthn

As more women die from abortion pill, the FDA approves a generic version

abortion pill, emergency contraception

 

The FDA has approved a generic version of the abortion pill Mifeprex, at a time when more deaths are being reported and the abortion industry is pushing for the dangerous abortion inducing chemicals to be dispensed online or by mail. According to a notice from the FDA, the generic version is approved for use as an abortifacient. This news comes just a day before the FDA updated its adverse effects reports through 2018, stating, “As of December 31, 2018, there were reports of 24 deaths of women associated with Mifeprex since the product was approved in September 2000, including two cases of ectopic pregnancy resulting in death; and several cases of severe systemic infection (also called sepsis), including some that were fatal…” The FDA’s 2017 report put the number of deaths at 22.

This means that in 2018 alone, two more women died from taking the abortion pill. And yet, now a generic version is going to be made available.

Abortion Pill Deaths December 2018

Dec 2018 abortion pill deaths FDA

To date, the report documents nearly 4,200 reported adverse effects, including hospitalization and other serious complications.

On April 11, 2019, the FDA approved GenBioPro, Inc.’s abbreviated new drug application for a generic Mifeprex, which, when used with Misoprostol is approved as an abortion pill regimen. The FDA states (emphasis added), “This approval reflects FDA’s determination that GenBioPro’s product, Mifepristone Tablets, 200 mg, is therapeutically equivalent to Mifeprex and can be safely substituted for Mifeprex. Like Mifeprex, the approved generic product is indicated for the medical termination of intrauterine pregnancy through 70 days gestation….”

READ: The secrecy surrounding the abortion pill’s maker and influential financial investors must end

Generic abortion pill by GenBioPro approved by FDA

The FDA also states clearly that although they modified the Mifeprex application to include “mifepristone products,” this change in no way removes the FDA’s REMS (Risk Evaluation and Mitigation Strategy), “a safety strategy to manage a known or potential serious risk associated with a medicine and to enable patients to have continued access to such medicines by managing their safe use.”

Of note, on April 11, 2019, FDA approved a supplemental application for Mifeprex, approving modifications to the existing approved REMS for Mifeprex to establish a single, shared system REMS for mifepristone products (including Mifeprex as well as the approved generic version of Mifeprex) for the medical termination of intrauterine pregnancy through 70 days gestation. In establishing the single, shared system REMS, no changes were made to the substantive elements of the REMS. This single, shared system REMS is known as the Mifepristone REMS Program.

Find approval information for this 2019 supplement here.

The approved generic version of Mifeprex generally has the same labeling as Mifeprex…Under the law, the approved generic version of Mifeprex is required to use a single, shared system REMS with the brand product, Mifeprex. This single, shared system REMS, known as the Mifepristone REMS Program, sets forth the distribution requirements that must be followed for both Mifeprex and the approved generic version of Mifeprex.

Requiring that the generic be subject to FDA’s REMS is good news for now, because, as Live Action News has previously reported, the abortion lobby is attempting to expand access to the abortion pills via mail order or pharmacy by pushing “self-managed abortion,” described by Guttmacher as ending a pregnancy “without direct supervision by a health care provider.” To accomplish this, REMS, must be eliminated.

READ: What you should know about the dangerous ‘self-managed’ abortion pill push

Dr. Donna Harrison, Executive Director American Association of Pro-Life Obstetricians and Gynecologists(AAPLOG), agreed, telling Live Action News (emphasis added):

Allowing a generic equivalent of Mifeprex basically means that the patent restrictions have run out. So, new drugs have a patent which is time limited… and in the case of Mifeprex, the patent was held by the Population Council. So, now that the patent has run out, generics are allowed. But this does not change the restrictions. REMS are still in place until FDA changes the restrictions. So, just to clarify, this does not mean that Mifeprex is OTC [over-the-counter]. It just changes how much quality control goes in to the pill manufacturing process and how much Danco can charge for the drug.

The move towards a generic drug is being hailed a victory by abortion advocates, specifically Dr. Daniel Grossman, who has deep tiesto the “self-managed” abortion pill push.

Image: FDA Approves generic abortion drug (Image Twitter Dr. Daniel Grossman)

FDA Approves generic abortion drug (Image Twitter Dr. Daniel Grossman)

Image: FDA Approves generic abortion drug NWHC (Image: Twitter)

FDA Approves generic abortion drug NWHC (Image: Twitter)

Under the Mifepristone REMS Program, the FDA states, “Mifeprex and the approved generic version of Mifeprex” may:

  • [O]nly be supplied directly to healthcare providers who are certified to prescribe the drug product and who meet certain qualifications.
  • [T]he products are only available to be dispensed in certain healthcare settings, specifically, clinics, medical offices and hospitals, by or under the supervision of a certified prescriber.
  • They are not available in retail pharmacies and are not legally available over the Internet.

The original drug (Mifeprex) was approved in 2000 after being brought to the U.S. by the eugenics-founded Population Council, and was seeded by the Packard Foundation among other pro-abortion philanthropy groups. They then set up a highly secretive company named Danco to manufacturer the drug.

The generic version is produced by GenBioPro, Inc., which also appears to have the financial support of abortion collaborators. In fact, Packard gave GenBioPro, Inc. $185,000 in 2016 and 100,000 in 2017. According to the Nevada Secretary of State, a 2007 filing for the company was permanently revoked. A new filing in 2011 is active and shows a registered agent of CSC Services of Nevada, Inc. and the only officer listed is E. Masingill.

The FDA warns consumers they should not buy Mifeprex or GenBioPro, Inc.’s approved generic version of Mifeprex, Mifepristone Tablets, 200 mg., over the Internet because they will bypass important safeguards designed to protect patient health.

    • This article is reprinted with permission. The original appeared here at Live Action News.

Abortion industry responsible for women dying from home use/ self managed abortions – here’s why!

Posted in Abortion death, Abortion pill, Abortionist, ACOG, Gynuity, Home Use Abortion, Planned Parenthood, Planned Parenthood Clinical Trials, RU-486, Self Managed Abortion with tags , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , on September 27, 2018 by saynsumthn

The abortion industry is now pushing dangerous home abortions

By  |  Via LiveActionNews.org

abortion

When the abortion industry speaks about women dying from “home abortions”, they leave out the fact that historically, they were the ones lined up to assist women in obtaining illegal abortions. Today, the trend seems to be continuing. “Abortion AMA: Can I give myself an abortion?” published weeks ago by Bustle and written by Danielle Campoamor, points out that even though abortion is legal in the US, groups like Women Help Women are advising women on “self managed abortions.”

Image: Bustle promotes self abortions

Bustle promotes self abortions

A June 2018 BBC article reported, “By buying pills online and sharing medical advice through WhatsApp groups, women are increasingly turning to technology to sidestep legal barriers to abortion.” Women on Web, an international group that helps women obtain illegal abortions, suggests women lie about complications and tell the doctors they had a miscarriage instead. Despite warnings against purchasing drugs online, activists Francine Coeytaux and Victoria Nichols created the website, PlanC, to push dangerous home abortions.

Joanna Erdman, assistant professor at Dalhousie University’s Schulich School of Law in Halifax, told the New York Times that Plan C is the “same feminist ideology of ‘self-help’ that guided the many safe-abortion initiatives before it, including, most notably, the Abortion Counseling Service of Women’s Liberation, or Jane.”

Image: Plan C pushes home abortions

Plan C pushes home abortions

Today, despite Roe v. Wade remaining firmly in place, the industry is pushing a legal version of “home use” abortion.

The move, being tested in clinical trials, would allow the drug Mifeprex to be mailed to women, or obtained over-the-counter at a local pharmacy. Mifeprex is regulated by the FDA under Approved Risk Evaluation and Mitigation Strategies (REMS), which ensures that Mifeprex is only dispensed in certain healthcare settings by or under the supervision of a certified prescriber.

The abortion-inducing regimen is made up of two pills: Mifeprex, also known as mifepristone, and misoprostol, which, according to the FDA, will end “an early pregnancy (70 days or less since the first day of the last menstrual period).” Of course, “the pregnancy” is a term for ending the life of a preborn child in the womb. But sometimes these chemicals also claim the lives of their mothers. This process is explained by Dr. Anthony Levatino in the video below:

 

Between May 2009 and February 2011, Clinical Trials “to assess the acceptability of home-use mifepristone” were conducted and reviewed in the United States, Moldova, and the Republic of Nepal, sponsored by Gynuity Health Projects. The sponsor sought to recruit 615 women between 18 to 55 to enroll in the non-randomized study, Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion. The trial within the USA included locations in three states — Georgia, New York and Pennsylvania:

Image: Feminist Women's Health Center home use abortion

Feminist Women’s Health Center home use abortion

Gynuity was founded in 2003 by Beverly Winikoff, M.D., M.P.H, and according to the website, “Winikoff was employed… at the Population Council.. Prior to joining the Council in 1978, she was Assistant Director for Health Sciences, The Rockefeller Foundation.”

Image: Gynuity Home Use Abortion

Senior Clinical Adviser Paul Blumenthal also currently serves as a member of the Board of Directors of the National Abortion Federation (NAF).

Gynuity is funded by organizations known for their support of abortion and population control, including:

  • The Bill and Melinda Gates Foundation
  • The David and Lucile Packard Foundation
  • The John D. and Catherine T. MacArthur Foundation
  • Planned Parenthood Global
  • Population Council
  • Society for Family Planning
  • The Rockefeller Foundation
  • The William and Flora Hewlett Foundation
Image: Abortion by Mail (Screen: The Atlantic)

Abortion by Mail (Screen: The Atlantic)

A report published by the pro-abortion journal ContraceptionAcceptability of Home-use of Mifepristone for Medical Abortion, reviewed a trial conducted from May 2009 through November 2010 at “four urban, demographically diverse clinical sites in New York City, Philadelphia and Atlanta…” which reported, “Four women in the home-use group and five women in the office-use group reported visiting the emergency room (ER) for care related to their abortion.”

Image: Home Use abortions send women to ER (Image: Journal Contraception)

Home Use abortions send women to ER (Image: Journal Contraception)

white paper overview written by authors at the Jacobs Institute of Women’s Health at George Washington University states, “More recent studies include one involving 400 women who received care at six US Planned Parenthood centers.” The Planned Parenthood home use study was conducted between April 2013 and June 2014, and results were published in Contraception, titled A prospective, non-randomized study of home use of mifepristone for medical abortion in the U.S, in 2015.

Abortion promoters are currently recruiting for a study at sites in California and Washington, where women will obtain the abortion pill regimen from the pharmacy instead of in the facility itself. Gynuity is also conducting clinical trials for the “Feasibility of Medical Abortion by Direct-to-Consumer Telemedicine,” or “mail order” abortion pills at select locations, including Planned Parenthood.

website, Teleabortion, has even been created to recruit for this experiment.

Image: Telabortion website

Telabortion website

While activists in favor of Roe and their complicit media allies claim abortion is safe, recent FDA reports indicate that almost a dozen women, who obtained pills at medical facilities, have died from it, and a thousand have been hospitalized.

Image: RU486 abortion pill deaths updated 2017

RU486 abortion pill deaths updated 2017

The real numbers may be difficult to track since, as Live Action News has previously documented, nearly half of all states do not require complications be reported. In addition, women suffering complications may present to the emergency room claiming they are suffering a miscarriage, without telling the truth about what has really happened.

In the years leading up to Roe v. Wade, advocates openly admitted that a majority of “illegal abortions” were being performed by “reputable physicians.” Past Planned Parenthood president Alan Guttmacher admitted to the Harvard Crimson in 1967 that “Seventy per cent of the illegal abortions in the country are performed by reputable physicians, each thinking himself a knight in white armor.”

Underground groups are already being formed to help commit “cheap, safe” abortions. There are also legal groups dedicated to “liberating” women who commit self-induced abortions. ACOG, which has shown itself to be pro-abortion, has also called for women to not be prosecuted for any self-induced abortions.

Regardless of the legal status of Roe v. Wade, women will continue to die, and the blame should be placed solely at the feet of the people who enable the killing to keep happening.

This article is reprinted with permission. The original appeared here at Live Action News.

$1 million to abortion clinics and Planned Parenthood for aborted fetal tissue from ABR

Posted in Aborted Baby Body Parts, Advanced Bioscience Resources (ABR), Center for Medical Progress, Chimeras, FDA, fetal research, Fetal Tissue, Planned Parenthood sells aborted baby parts with tags , , , , , , , , on September 6, 2018 by saynsumthn

Planned Parenthood got over $300,000 in 6 years from one fetal tissue harvester

Planned Parenthood

Live Action News recently reported about how the FDA is contracting with Advanced Bioscience Resources (ABR) to obtain “fresh human tissues” — aborted fetal body parts — “for implantation into severely immune-compromised mice to create chimeric animals that have a human immune system.” ABR’s history with fetal tissue research goes back years. According to the Center for Medical Progress, ABR is “the largest and oldest fetal tissue seller in the U.S.” It was founded in 1989, and is the primary supplier of fetal tissue for the U.S. government. And it has paid numerous abortion facilities a great deal of money for this tissue — including a number of Planned Parenthood centers.

The stunning graphic below from the House Select Investigative Panel report summarizes known ABR payments to various Planned Parenthood facilities for fetal tissue — totaling more than $350,000 over the course of six years, from 2010 to 2015:

Image: ABR 2015 Fetal Sales to Top 5 Customers Product and Totals (Image credit: Congressional Investigation)

ABR 2015 Fetal Sales to Top 5 Customers Product and Totals (Image credit: Congressional Investigation)

According to a 2015 report from Politico:

The Food and Drug Administration has also paid about $73,000 to the company since 2009… mostly for liver and thymus tissue that are used largely to develop a human-like immune system in mice…. The NIH, with a $30 billion budget for research nationwide, funded about $76 million in dozens of fetal tissue projects in 2014.

Image: FDA Chimeric fetal tissue research

FDA Chimeric fetal tissue research

The FDA has a dozen contracts with ABR for various items, including lab equipment and supplies, according to the General Services Administration’s Federal Procurement Data SystemOnline records at the National Institutes of Health (NIH) indicate ABR is regularly granted federal dollars for various projects.

READ: FDA buys ‘fresh’ aborted body parts from company referred for criminal charges

The 2015 Congressional investigation regarding the illegal sale of fetal body parts, following undercover videos released by CMP, led to a report. In this report, quoted below, it was revealed that ABR had been contracting with universities and abortion facilities for years:

  • Before [founder and CEO Cate Dyer] began StemExpress, she worked for Advanced Bioscience Resources, Inc. (ABR)
  • The University of Minnesota (UM)… obtains fetal tissue from procurement companies—in this case, Advanced Bioscience Resources (ABR) and StemExpress—in addition to an area clinic.
  • The University of Wisconsin, School of Medicine and Public Health (UW SMPH)… more recently obtained fetal tissue for research from the Albert Einstein College of Medicine, UW, and ABR.
  • Colorado State University (CSU)… receives a significant amount in federal grants and obtains much of its fetal tissue from ABR and StemExpress. Between 2010 and 2015, CSU received seven NIH grants to support their projects using fetal tissue, at a taxpayer expense of $3.5 million.
  • According to productions made by 25 clinics from which ABR has received fetal tissue, ABR paid them a total of $1,002,147 from 2010 to 2015…. The chart below shows ABR facility fee payments from 2010 through 2015 to the abortion clinics from which it obtained fetal tissue:
Image: ABRs abortion clinic facility fees 2010 to 2015 (Image credit” Select Panel investigation of fetal tissue)

ABRs abortion clinic facility fees 2010 to 2015 (Image credit” Select Panel investigation of fetal tissue)

The panel then detailed ABR’s 2015 fetal parts sales to its top five customers:

Image: ABR 2015 Fetal Sales to Top 5 Customers Product and Totals (Image credit: Congressional Investigation)

ABR 2015 Fetal Sales to Top 5 Customers Product and Totals (Image credit: Congressional Investigation)

In a letter from Rep. Marsha Blackburn to the then-District Attorney of Riverside, California, the Congresswoman detailed ABR’s relationship with Planned Parenthood:

Image: ABRs interactions with Planned Parenthood fetal tissue

ABRs interactions with Planned Parenthood fetal tissue (Image credit: Letter from Rep. Marsha Blackburn)

In 2016, Houston attorney Briscoe Cain claimed he found evidence of four Texas medical schools purchasing fetal tissue from ABR. Invoices from to one of the schools, given to KFOX14 Investigates and reported by CBS4, show the school paid at least $4,000-$5,000 for fetal parts including livers, spleens and thymuses.

Image: ABR invoices for fetal tissue to Texas Universities

ABR invoices for fetal tissue to Texas Universities

Image: ABR invoices for fetal parts to Texas Universities

ABR invoices for fetal parts to Texas Universities

“The research being done is humanized mice. Scientists inject the mouse with fetal tissue so the mouse is genetically altered to accept the graphing of human tissue,” Cain said at the time.

In 2011, the University of Minnesota contracted with ABR for “human fetal pancreas tissue” between 16-24 weeks.

Image: ABR contract with U of Minnesota for fetal tissue 2011

ABR contract with U of Minnesota for fetal tissue 2011

In 2000, the Government Accountability Office (GAO) was tasked to study “the involvement of federal agencies under the jurisdiction of the Senate Committee on Appropriations, Subcommittee on Labor, Health and Human Services, and Education in the acquisition of human fetal tissue for biomedical research.” The Department of Health and Human Services (HHS) told GAO that “NIH is the only federal agency under the Labor, HHS, and Education Subcommittee’s jurisdiction that sponsors research using human fetal tissue.” But Live Action previously showed that the EPA used aborted fetal tissue for research in the 1970’s.

According to that report, NIH sponsored three central human fetal tissue supply organizations:

  • The Birth Defects Laboratory at the University of Washington, which distributed 2,869 human fetal tissue samples and collected $52,035 in fees directly from researchers in fiscal year 1999.
  • The Brain and Tissue Banks for Developmental Disorders at the University of Maryland and the University of Miami School of Medicine/Children’s Hospital of Orange County, primarily to serve as suppliers of human nonfetal tissue…. The University of Maryland Bank provided 195 human fetal tissue samples to investigators in fiscal year 1999, and the University of Miami Bank provided approximately 40 samples between March 1 and August 31, 1999.

GAO states that researchers also obtained human fetal tissue from private organizations that did not directly receive federal funds, including ABR.

Abortion strategy to fund abortion and bio-waste facilities, pass legislation

Posted in Abortion Strategy, ANSIRH, Guttmacher, Reproductive Health Investors Allianc, TARA Health Foundation with tags , , , , , , , , , , , , , , , , , , , , , , on September 6, 2018 by saynsumthn

EXPOSED: Abortion groups’ plan to ‘increase supply and demand’ for abortion

A 92-page report on the Tara Health Foundation website should be reviewed by pro-life advocates across the nation, as it details upcoming strategy from abortion supporters, which includes the push for “home use” abortions. Live Action News has previously covered how the philanthropic Foundation is behind funding RU-486 pills on college campuses in California and behind propping up the abortion chain Whole Woman’s Health while it battled safety regulations in Texas.

The “US Reproductive Health Investment Case” report from October of 2017 was put together by the “Reproductive Health Investors Alliance… to determine the most effective opportunities to improve access to reproductive health services… using both philanthropy and impact investments.” The report’s stated goal? “To increase the supply of and demand for… contraceptive and abortion services.”

Image: TARA Reproductive Health Investors Alliance Goal

TARA Reproductive Health Investors Alliance Goal

Image: Reproductive Health Investors Alliance Steering Committee

Reproductive Health Investors Alliance Steering Committee

The report includes statistics and analysis from “ANSIRH, the Guttmacher Institute, Ibis Reproductive Health, and the Kaiser Family Foundation.”

It should be noted that these agencies have abortion connections:

“Experts” who contributed to the report include:

The executive summary begins by pointing out the target:

… specific demographic groups (18-19 year olds, Black [WOC] and Hispanic women, and low-income women) that lag behind the national average in their rates of contraceptive use, the efficacy of contraceptives used and timing of abortion.

Live Action News has documented time and again that minority groups, which have a disproportionately high rate of abortion, are the target of the population control movement.

Image: TARA Reproductive Health Investors Alliance targeting women of color

TARA Reproductive Health Investors Alliance targeting women of color

The report identifies “40 example investment opportunities,” matched to “five challenge-specific investment strategies”:

a) research and development,
b) legislation & litigation,
c) pricing & reimbursement,
d) service provision, and
e) care-seeking by underserved populations

As Live Action News has documented, the report states that, “~50% of abortions are repeat abortions (460K abortions/year)” and it defines “woman” as those “in need of high quality contraceptive and abortion services” though the report “acknowledge[s] that this is a vast simplification.” The report also adds, “The term ‘woman’ does not describe the identity of all persons who can get pregnant; conversely, not all those who identify as a woman can get pregnant.”

Image: TARA Reproductive Health Investors Alliance legislative strategies

TARA Reproductive Health Investors Alliance legislative strategies

Pro-abortion legislative and litigation strategies suggested in the report include:

  • REMS removal strategy (This is the risk management system that governs the abortion pill RU486)
  • TRAP laws removal advocacy
  • Gestational bans removal advocacy
  • Criminality of self-induced abortion removal advocacy
  • Organizing led by women of color
  • Reproductive health or democracy reform PAC donations
  • Reproductive justice PAC donations

Image: Reproductive Health Investors Alliance abortion clinic strategy 1 of 2

Reproductive Health Investors Alliance strategy 1 of 2

Strategies that benefit abortion facilities include:

  • Investment in a biowaste facility that will collect from the facilities
  • Upstream investment to secure supply of firms able to build the facilities
  • Guarantees that enable the facilities to take out market rate loans
  • Readily available real estate or rental agreements for the facilities
  • Facilitate and train NPs, CNMs, PAs to commit abortions
  • Provide funding or loans for independent providers to join a telemedicine network
  • Innovations in telemedicine, mobile services, or at-home services that improve access
  • Provide free pregnancy diagnosis in abortion facilities to combat pregnancy resource centers

Image: Reproductive Health Investors Alliance abortion clinic strategy 2 of 2

Reproductive Health Investors Alliance strategy 2 of 2

Statistics from report unintentionally point to pro-life advances:

  • Since 2010, 338 state abortion restrictions have been adopted.
  • 90% of all U.S. counties lack an abortion provider.
  • 162 abortion providers closed down between 2011-2016. Only 21 abortion facilities opened during the same period.
  • An estimated 16 abortion facilities close each year due to financial challenges.
  • As of 2008, 97% of nonmetropolitan counties lacked an abortion provider.
  • There are an estimated 2,300 to 3,500 CPCs in the U.S. while there are only 1,800 abortion facilities.
  • Pregnancy resource centers outnumber these facilities 2:1.
  • Cost and difficulty getting malpractice insurance for independent providers is one of the biggest financial challenges for already resource strapped abortion facilities.
  • Viewing an ultrasound may contribute to a small proportion of women with medium or low decision certainty deciding to continue the pregnancy.
  • More than a third of Planned Parenthood’s budget comes from Medicaid, putting Planned Parenthood at risk if Medicaid funding is blocked.

The report proves the length abortion supporters intend to go to in order to guarantee the “right” to end the lives of tiny humans persons in the womb. And it clearly shows the impact that pro-life legislation, pro-life activism, and pro-life pregnancy centers are having on the abortion industry.

This article is reprinted with permission. The original appeared here at Live Action News.